Filter Results:
(354)
Show Results For
- All HBS Web
(354)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
Show Results For
- All HBS Web
(354)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
- 06 May 2008
- First Look
First Look: May 6, 2008
Fibrosis Foundation: Venture Philanthropy Funding for Biotech Harvard Business School Case 808-005 In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora... View Details
Keywords: Martha Lagace
Eric Boutin
Longwood Fund, a life sciences venture capital fund, where he led early-stage biotech deals and founded Flex Pharma, a neuromuscular sports performance company, which went on to IPO (NASDAQ: FLKS). Eric holds an MBA from Harvard Business... View Details
Keywords: Healthcare
- 24 Apr 2014
- News
A founding father of Silicon Valley venture capital guides entrepreneurs
Throughout his long career as a venture capitalist, Franklin “Pitch” Johnson (MBA 1952) has worked primarily in the biotech industry, earning a reputation as a thoughtful investor, trusted adviser, and generous philanthropist. In 1962,... View Details
- 01 Jun 2001
- News
Christina Ehrenberg: The Examined Life
Goldman Sachs in asset management with a biotech focus. Of her HBS experience, Ehrenberg says, “Unlike the rote, top-down German education system, here you are an equal partner in ongoing learning and discussion. HBS has made me more... View Details
- 01 Dec 2013
- News
Your Own Medicine
searching for new leads. In 2008, Benjy came across an article on halofuginone (HT-100), a drug compound derived from an ancient Chinese herb that had shown promising results in treating muscular dystrophy in mice. They tracked it down to an Israeli View Details
- 13 Aug 2019
- Blog Post
What is the MS/MBA Biotechnology: Life Sciences Program?
joint degree? Who should apply for this program instead of solely the MBA? What are the admissions requirements? What will the coursework be like? What are the potential career paths for MS/MBA Biotech grads? Clear Admit’s Graham... View Details
- 01 Oct 2021
- News
Tackling the World’s Most Difficult Challenges
Sarnoff Professor of Business Administration, have long studied how artificial intelligence (AI) is changing the competitive landscape, but the example they explore in their “Moderna” case study is perhaps the most dramatic. The case takes students inside the View Details
- 01 Oct 1999
- News
Finance Conference Explores Research Methodologies
HBS assistant professor George Chacko, and HBS doctoral candidate Geoffrey Verter that looked at how risk management theory could be applied to understand a biotech firm's decision to buy call options on its own stock. In the final... View Details
- 27 Sep 2019
- Blog Post
HBS Alumni and Students Take On the Climate Crisis
prairies west of Houston to mitigate the environmental impact of development through investment in conserving water-absorbing grasslands. THE BLUE-GREEN REVOLUTION Synthetic Genomics Inc., a private biotech company co-founded by Juan... View Details
- 01 Mar 2008
- News
Alumni Books
sweet spot; designing the offer to create customer value and secure differential advantage; integrating to serve the customer; and measuring what matters. Science Lessons: What the Business of Biotech Taught Me about Management by Gordon... View Details
- Web
IFC: Singapore; Shaping a Global Innovation Hub - Course Catalog
secured a strong lineup of speakers, each leaders in their respective fields, to offer students a broad range of perspectives as they engage with the coursework. Educational Objectives Through immersing students in Singapore’s burgeoning View Details
- 01 Jan 2006
- News
Philip L. Yeo, MBA 1976
R&D," explains Yeo. "A short time later, I set up the EDB's Singapore Bio Innovation Fund to invest longterm in overseas start-ups to learn as much as possible about the nascent biotech industry. And on June 26, 2000, the day the United... View Details
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
science-based research is something the heads of top biotech and pharmas learned long ago: There are few instant payoffs to please investors. Just ask Raymond Gilmartin, former chairman, president, and CEO of Merck & Co., who now... View Details
- 17 Dec 2001
- Research & Ideas
Enterprising Women
by the firm's mission and saw that it had been self-sufficient for nearly seven years, Fisher's task became much easier: In three stages, over the course of 2000, she raised venture capital funds of $11 million, $48 million, and $75 million. That same year, she founded... View Details
Keywords: by Julia Hanna
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
Association’s conference held on campus in early November. The three-day conference included presentations by industry executives, government officials, and HBS faculty on topics ranging from trends in the biotech and pharmaceutical... View Details
- Web
Middle East & North Africa - Global Activities 2021
Graduate School of Arts and Sciences, and Harvard Medical School through the Harvard Department of Stem Cell and Regenerative Biology—to explore biotech careers in emerging markets, particularly in the Middle East and North Africa region.... View Details
- Profile
Arjun Goyal
always at the back of my mind.” HBS stood out for two reasons. “It has a great network of alumni and professors in the biotech and pharmaceutical fields — both in world-leading corporations and start-ups,” says Arjun. “And HBS has a... View Details
- Profile
Yaping Wang
semester, Yaping sought free coaching from HBS that helped her speak with greater confidence. "I think being comfortable reaching out for help is an important thing to learn; it doesn't have to be associated with being weak." As Yaping prepares for a summer... View Details
- 05 Oct 2016
- News
Harvard to Open Life Sciences Lab
possible by a gift from Judy (MBA 1983) and Steve Pagliuca (MBA 1982), the lab will offer shared space for high-potential life sciences and biotech startups that are founded by Harvard faculty, alumni, students, and postdoctoral scholars.... View Details
- 01 Sep 2015
- Blog Post
Building a Startup at HBS
direct patient care in a hospital, to biotech investing in New York and Boston, the Vein Whisperer has continued to keep our team united. Moving forward, we’re working remotely to finalize our patents and will continue to build the... View Details